{"id": "chatcmpl-8JW7XqwiDyLeVvIZlvqPBQGv1aECb", "object": "chat.completion", "created": 1699662395, "model": "gpt-4-0613", "choices": [{"index": 0, "message": {"role": "assistant", "content": "1. A1C at week 24 was measured in both the etanercept group and the placebo group.\n2. The A1C level at week 24 in the etanercept group was 5.91 \u00b1 0.5%.\n3. The A1C level at week 24 in the placebo group was 6.98 \u00b1 1.2%.\n4. The A1C level at week 24 was lower in the etanercept group compared to the placebo group.\n5. The difference in A1C levels between the etanercept group and the placebo group at week 24 was statistically significant (P < 0.05).\n6. The percent decrease from baseline in A1C was measured in both the etanercept group and the placebo group.\n7. The percent decrease from baseline in A1C was higher in the etanercept group than in the placebo group.\n8. The percent decrease from baseline in A1C in the etanercept group was 0.41 \u00b1 0.1."}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 106, "completion_tokens": 223, "total_tokens": 329}, "temperature": 0, "max_tokens": 512, "top_p": 1, "frequency_penalty": 0, "presence_penalty": 0, "messages": [{"role": "system", "content": "Statement: A1C at week 24 was lower in the etanercept group (5.91 \u00b1 0.5%) compared with that in the placebo group (6.98 \u00b1 1.2%; P < 0.05) with a higher percent decrease from baseline than in the placebo group (etanercept 0.41 \u00b1 0.1 vs.\n\nList all the facts we explicitly know from the statement. Make each fact as atomic as possible."}]}